Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.1.1.37 (
DNA methyltransferase
)
4,983
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We report here the discovery of
HMBP
, a protein in nuclei of human T-helper lymphocytes and other human cell types, which binds with enhanced affinity to a promoter element in the HIV-1 long terminal repeat when that element is methylated at CpGs, the target site of the human
DNA methyltransferase
. This promoter element contains three (degenerate) binding sites for Sp1, a general activator of transcription. Gel shift assays and footprinting experiments indicate that
HMBP
binding overlaps two of these methylated Sp1 sites. Although
HMBP
binds these methylated Sp1 sites, it does not bind consensus Sp1 sites. Competition studies, differences in binding site specificities, binding conditions, and, in some cases, chromatographic separation further distinguish
HMBP
from Sp1 and from each of four previously identified methylated-DNA binding proteins.
HMBP
binds hemimethylated DNA in a strand dependent manner. These binding characteristics suggest that
HMBP
may recognize newly replicated DNA and thereby play a role in differentiation. If
HMBP
is able to compete with Sp1 for binding at methylated, non-consensus Sp1 sites in vivo and repress transcription, it may play a role in AIDS latency.
...
PMID:A nuclear protein with enhanced binding to methylated Sp1 sites in the AIDS virus promoter. 828 30